Pleural Effusion in Patients With End-Stage Liver Disease Who Are Candidates For Transplant

被引:1
|
作者
Dogrul, Mustafa Ilgaz [1 ]
Akcay, Sule [1 ]
Bozbas, Serife Savas [1 ]
Dedekarginoglu, Balam Er [1 ]
Eyuboglu, Fasun Oner [1 ]
Moray, Gokhan [2 ]
Haberal, Mehmet [2 ]
机构
[1] Baskent Univ, Fac Med, Dept Pulm Med, TR-06490 Ankara, Turkey
[2] Baskent Univ, Fac Med, Dept Gen Surg & Transplantat, TR-06490 Ankara, Turkey
关键词
Pleural effusion; Liver transplant; Preoperative; HEPATIC HYDROTHORAX; LATIN-AMERICA; MANAGEMENT; CIRRHOSIS; DIAGNOSIS; ASCITES;
D O I
10.6002/ect.25Liver.P31
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Objectives: The purpose of this retrospective study was to determine the rate of occurrence and features of pleural effusion in patients referred to our institution for liver transplant. Materials and Methods: This study included 135 patients (43 women, 92 men) with a mean age of 40 years (range, 16-66 y). Patient characteristics such as history of pulmonary disease and types of respiratory symptoms were recorded. The chest radiographs of every study patient were examined. Results: Of the 135 study patients, 16 (11.9%) had respiratory symptoms upon admission to the hospital, and 49 (36.3%) had abnormalities on their chest radiographs. The most common radiographic abnormality was elevated right hemidiaphragm in 32 patients (23.7%), followed by pleural effusion in 22 (16.2%), atelectasis in 21 (15.5%), hilar enlargement in 18 (13.3%), and elevated left hemidiaphragm in 9 (6.6%). Seventeen of 22 patients (77.3%) had right pleural effusion, 4(18.2%) had bilateral, and 1 (4.5%) had left pleural effusion. Of the 10 patients undergoing thoracentesis, 9 had transudates and 1 had an exudate. Conclusions: Preoperative pleural effusion is a common problem in patients who are candidates for a liver transplant. Most of these patients have right transudative pleural effusion.
引用
收藏
页码:149 / 152
页数:4
相关论文
共 50 条
  • [41] Oral management of the patient with end-stage liver disease and the liver transplant patient
    Douglas, LR
    Douglass, JB
    Sieck, JO
    Smith, PJ
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1998, 86 (01): : 55 - 64
  • [42] End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates
    Sharma, Pratima
    Schaubel, Douglas E.
    Gong, Qi
    Guidinger, Mary
    Merion, Robert M.
    HEPATOLOGY, 2012, 55 (01) : 192 - 198
  • [43] Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates
    Swenson, Sonja M.
    Roberts, John P.
    Rhee, Sue
    Perito, Emily R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (12) : 3308 - 3318
  • [44] Survival and quality of Life for children with end-stage heart failure who are not candidates for cardiac transplant
    Sabati, Arash Alen
    Szmuszkovicz, Jacqueline R.
    Herrington, Cynthia
    Hermes, Mark
    Mahmoud, Hesham A.
    Wee, Choo Phei
    Starnes, Vaughn A.
    Menteer, JonDavid
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (07): : 906 - 911
  • [45] Validation of the Model for End-Stage Liver Disease 3.0 in Korean Patients on the Liver Transplant Waiting List
    Yang, Jiwon
    Park, Jung-bin
    Shim, Ju hyun
    Lim, Young-suk
    Lee, Han chu
    Choi, Jonggi
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (13) : 3437 - +
  • [46] Comparative Effectiveness of Liver Transplant Strategies for End-Stage Liver Disease Patients on Renal Replacement Therapy
    Chang, Yaojen
    Gallon, Lorenzo
    Jay, Colleen
    Shetty, Kirti
    Ho, Bing
    Levitsky, Josh
    Baker, Talia
    Ladner, Daniela
    Friedewald, John
    Abecassis, Michael
    Hazen, Gordon
    Skaro, Anton I.
    LIVER TRANSPLANTATION, 2014, 20 (09) : 1034 - 1044
  • [47] Cardiovascular dysfunction in patients with end-stage liver disease
    Mandell, Merceds Susan
    Tsou, Mei-Yung
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2008, 71 (07) : 331 - 335
  • [48] Safety of regadenoson in patients with end-stage liver disease
    Wael AlJaroudi
    Fahad Iqbal
    Jayanth Koneru
    Pradeep Bhambhvani
    Jaekyeong Heo
    Ami E. Iskandrian
    Journal of Nuclear Cardiology, 2011, 18 : 90 - 95
  • [49] The coagulation system in patients with end-stage liver disease
    Valla, Dominique-C.
    Rautou, Pierre-E.
    LIVER INTERNATIONAL, 2015, 35 : 139 - 144
  • [50] Palliative Care for Patients with End-Stage Liver Disease
    Larson A.M.
    Current Gastroenterology Reports, 2015, 17 (5)